Material_Disposal_Services_QUESTIONS_and_Answers.docx

Material Disposal Services QUESTIONS and ANSWERS

Are there any incumbent contracts currently fulfilling the work outlined under 2013N15650?

Solicitation 2013N15650 is a new acquisition and has no incumbent.

I have a question concerning the hazardous waste statement below. Specifically the MSDS issue, are you asking that we supply the MSDS for the hazardous products coming from your facilities?

d) The apparently successful offeror agrees to submit, for each item as required prior to award, a Material Safety Data Sheet, meeting the requirements of 29 CFR 1910.1200(g) and the latest version of Federal Standard No. 313, for all hazardous material identified in paragraph (b) of this clause. Data shall be submitted in accordance with Federal Standard No. 313, whether or not the apparently successful offeror is the actual manufacturer of these items. Failure to submit the Material Safety Data Sheet prior to award may result in the apparently successful offeror being considered nonresponsible and ineligible for award.

CDC will provide MSDS as required.

After reading through the RFP, the section titled “Payment” contained some verbiage and instruction which raised some questions. I posted the Payment section below with the portion in question underlined.

PAYMENTS

The payments shall not be made until credits are received and shall be based on the actual credits, not estimated or anticipated credits, thereby increasing the contractor's incentive to obtain maximum credit amounts. The payments to the reverse distributor for both their return and disposal services will be paid by the pharmaceutical Prime Vendor from the manufacturer credits received. The exact payment amount to be tendered shall be addressed in a separate agreement between the Contractor and the Prime Vendor and may include a reasonable administrative fee charged by the Prime Vendor from the MTF credit account.

The questions I have are as follows:

1. Does the CDC utilize a Prime Vendor for the purchasing of the drugs contained in their stockpile (the items to be returned for credit)?

We will be using Purchasing Partners Prime Vendor Contract

1. Are any of these items purchased at a discount with limited return for credit privileges or with no return for credit privileges? If so, will these be made known prior to any service event?

Not to our knowledge

1. If the amount of material returned for credit is not sufficient to pay the fees, what will be the recourse for payment?

Submit invoice to CDC for Payment in accordance with this solicitation

1. The payment section stipulates that the return credits are to be used to pay the services associated with disposal and return for credit. What about the fees associated with transportation?

Vendor’s responsibility